Precision BioScience Secures $25,600,000 Series A Financing
Feed Type
Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=c0dc8b7b-49e5-4853-84b2-e08d3b2e7ff4
Date 5/12/2015
Company Name Precision BioScience
Mailing Address 302 East Pettigrew St. Durham, NC 27701 USA
Company Description Precision BioSciences’ mission is to translate the world’s most powerful genome editing technology into greatly needed products throughout the life sciences. Precision’s proprietary ARCUS genome editing technology enables the production of highly specific nucleases that can insert, remove, and modify DNA at essentially any location in a complex genome.
Proceeds Purposes This financing will allow us to expand beyond our successful efforts to develop the leading next-gen genome editing platform and significantly accelerate the development of our genome-edited product pipeline.